Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 21, 2011; 17(31): 3605-3613
Published online Aug 21, 2011. doi: 10.3748/wjg.v17.i31.3605
Published online Aug 21, 2011. doi: 10.3748/wjg.v17.i31.3605
Figure 7 Survival time and survival rate of mice bearing hep1-6 tumor.
The forty mice were divided into 4 groups with ten in each group, and inoculated with 1 × 106 Hep1-6 cells in each mouse. The mice were given an intratumoral injection of ginsenoside Rg3 (Rg3) (3.0 mg/kg) and cyclophosphamide (CTX ) (20.0 mg/kg) or saline (1.5 mg/kg) for 10 d following inoculation of Hep1-6 cells. The animal survival study was followed up to 102 d, to observe and compare their survival time and survival rate. The Rg3 and CTX combination group, Rg3 group, and CTX group were statistically significant compared with the saline injected control group. Rg3: Ginsenoside Rg3; CTX: cyclophosphamide.
-
Citation: Jiang JW, Chen XM, Chen XH, Zheng SS. Ginsenoside Rg3 inhibit hepatocellular carcinoma growth
via intrinsic apoptotic pathway. World J Gastroenterol 2011; 17(31): 3605-3613 - URL: https://www.wjgnet.com/1007-9327/full/v17/i31/3605.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i31.3605